Literature DB >> 23154211

Best allograft survival from share-35 kidney donors occurs in middle-aged adults and young children-an analysis of OPTN data.

Asha Moudgil1, Vikas R Dharnidharka, Kenneth E Lamb, Herwig-Ulf Meier-Kriesche.   

Abstract

BACKGROUND: On October 2005, the Organ Procurement and Transplant Network implemented a new allocation policy for kidney transplants (KTX) from deceased donors (DD) ages <35 years to increase an access to transplantation from young donors for pediatric (ages <18 years) recipients, which is known as Share-35 (S35). However, many of these kidneys were allocated to adult recipients. The intent of this study was to analyze the graft outcomes from S35 kidneys in pediatric and adult recipients, stratified further by recipient age, to assess if recipient age affects the outcome from these presumably ideal kidneys.
METHODS: The Organ Procurement and Transplant Network database from October 2005 to November 2010 involving 18,461 S35-KTX was used to calculate cumulative graft survival (CGS), death-censored graft survival, and patient survival using Kaplan-Meier estimates. The differences between survival curves were tested for significance by log-rank method after adjusting for various donor, recipient, and transplant-associated variables.
RESULTS: With S35 implementation, children received a higher proportion of DD ages <35 years. Within the pediatric age group, adolescents (ages 13-17 years) had the worst CGS. Among adults, the highest CGS was obtained in middle-aged adults, whereas young adults (ages 18-25 years) showed worse CGS. CGS in young children (ages <12 years) was comparable with those in middle-aged adults. In older adults (ages >55 years), CGS was lowered by higher patient death rates.
CONCLUSIONS: Recipient age affects allograft survival from high-quality young DD kidneys, such as S35 kidneys. Best survival occurs in middle-aged adults and in children ages <12 years, whereas adolescents and young adults do not derive an optimal benefit.

Entities:  

Mesh:

Year:  2013        PMID: 23154211     DOI: 10.1097/TP.0b013e3182719203

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  7 in total

Review 1.  Pediatric kidney transplantation: a historical review.

Authors:  Priya S Verghese
Journal:  Pediatr Res       Date:  2016-10-12       Impact factor: 3.756

2.  Repeat Kidney Transplantation After Failed First Transplant in Childhood: Past Performance Informs Future Performance.

Authors:  Meera Gupta; Alexander Wood; Nandita Mitra; Susan L Furth; Peter L Abt; Matthew H Levine
Journal:  Transplantation       Date:  2015-08       Impact factor: 4.939

3.  Introducing a New Technique for Fascial Closure to Avoid Renal Allograft Compartment Syndrome in Pediatric Recipients: The Use of Tutoplast® Fascia Lata.

Authors:  Beatriz Bañuelos Marco; Berenice Bergel; Tamara Geppert; Dominik Müller; Anja Lingnau
Journal:  Front Surg       Date:  2022-05-06

4.  Pediatric Renal Transplantation in Oman: A Single-center Experience.

Authors:  Mohamed S Al Riyami; Sulaiman Al Saidi; Badria Al Ghaithi; Anisa Al Maskari; Sadiq Lala; Nabil Mohsin; Lekha Hirshikesan; Naifain Al Kalbani
Journal:  Oman Med J       Date:  2018-01

5.  Phase I study of single-dose pharmacokinetics and pharmacodynamics of belatacept in adolescent kidney transplant recipients.

Authors:  Asha Moudgil; Vikas R Dharnidharka; Daniel I Feig; Barry L Warshaw; Vidya Perera; Bindu Murthy; Mustimbo E Roberts; Martin S Polinsky; Robert B Ettenger
Journal:  Am J Transplant       Date:  2019-01-22       Impact factor: 8.086

6.  Predictors and one-year outcomes of patients with delayed graft function after deceased donor kidney transplantation.

Authors:  Rao Chen; Haifeng Wang; Lei Song; Jianfei Hou; Jiawei Peng; Helong Dai; Longkai Peng
Journal:  BMC Nephrol       Date:  2020-12-04       Impact factor: 2.388

7.  Extraperitoneal pediatric kidney transplantation of adult renal allograft using an en-bloc native liver and kidney mobilization technique.

Authors:  Mahmoud Alameddine; Joshua S Jue; Mahmoud Morsi; Javier Gonzalez; Marissa Defreitas; Jayanthi J Chandar; Jeffrey J Gaynor; Gaetano Ciancio
Journal:  BMC Pediatr       Date:  2020-11-16       Impact factor: 2.125

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.